Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-01 11:16 am Purchase |
2022-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
FEDERATED HERMES INC. FHI |
1,201,275 22.500% |
1,201,275 (New Position) |
Filing History |
| 2023-02-01 11:06 am Purchase |
2022-12-31 | 13G | Merus N.V. MRUS |
FEDERATED HERMES INC. FHI |
3,924,295 8.480% |
244,995 (+6.66%) |
Filing History |
| 2023-02-01 10:58 am Purchase |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
FEDERATED HERMES INC. FHI |
2,864,500 5.950% |
574,218 (+25.07%) |
Filing History |
| 2023-02-01 10:46 am Sale |
2022-12-31 | 13G | Dynavax Technologies Corporation DVAX |
FEDERATED HERMES INC. FHI |
12,640,363 9.910% |
-4,142,475 (-24.68%) |
Filing History |
| 2023-02-01 10:39 am Purchase |
2022-12-31 | 13G | CASI Pharmaceuticals, Inc. CASI |
FEDERATED HERMES INC. FHI |
900,651 6.620% |
900,651 (New Position) |
Filing History |
| 2023-02-01 10:29 am Purchase |
2022-12-31 | 13G | aTyr Pharma, Inc. ATYR |
FEDERATED HERMES INC. FHI |
5,231,600 18.030% |
5,231,600 (New Position) |
Filing History |
| 2023-02-01 10:21 am Unchanged |
2022-12-31 | 13G | Aris Water Solutions, Inc. ARIS |
FEDERATED HERMES INC. FHI |
2,588,600 9.760% |
0 (Unchanged) |
Filing History |
| 2023-02-01 10:11 am Purchase |
2022-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
FEDERATED HERMES INC. FHI |
4,239,554 16.000% |
544,625 (+14.74%) |
Filing History |
| 2023-02-01 10:07 am Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
FEDERATED HERMES INC. FHI |
3,057,800 6.420% |
1,032,200 (+50.96%) |
Filing History |
| 2023-02-01 09:49 am Purchase |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
FEDERATED HERMES INC. FHI |
2,373,023 8.350% |
1,053,850 (+79.89%) |
Filing History |
| 2023-02-01 09:43 am Sale |
2022-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
3,284,217 6.800% |
-180,118 (-5.20%) |
Filing History |
| 2023-02-01 09:41 am Purchase |
2022-12-31 | 13G | Alector, Inc. ALEC |
FEDERATED HERMES INC. FHI |
4,571,660 5.530% |
4,571,660 (New Position) |
Filing History |
| 2023-02-01 09:07 am Sale |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
FEDERATED HERMES INC. FHI |
1,956,488 9.450% |
-402,136 (-17.05%) |
Filing History |
| 2023-02-01 09:03 am Purchase |
2022-12-31 | 13G | MALLINCKRODT PLC SHS MNKTQ |
FEDERATED HERMES INC. FHI |
998,958 7.580% |
998,958 (New Position) |
Filing History |
| 2023-02-01 08:56 am Purchase |
2022-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
3,224,100 7.200% |
3,224,100 (New Position) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Federated Hermes, Inc. FHI |
BLACKROCK INC BLK |
12,326,018 13.900% |
0 (Unchanged) |
Filing History |
| 2023-01-20 3:00 pm Sale |
2022-12-31 | 13G | Federated Hermes, Inc. FHI |
BLACKROCK INC BLK |
12,326,018 13.900% |
-209,197 (-1.67%) |
Filing History |
| 2023-01-10 08:47 am Sale |
2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
FEDERATED HERMES INC. FHI |
3,094,500 4.410% |
-892,370 (-22.38%) |
Filing History |
| 2023-01-10 08:35 am Sale |
2022-12-31 | 13G | Omega Alpha SPAC OMEG |
FEDERATED HERMES INC. FHI |
0 0.000% |
-1,000,000 (Position Closed) |
Filing History |
| 2023-01-10 08:31 am Sale |
2022-12-31 | 13G | Akouos, Inc. AKUS |
FEDERATED HERMES INC. FHI |
0 0.000% |
-3,897,903 (Position Closed) |
Filing History |